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ABSTRACT
Infections caused by the bacterium Staphylococcus aureus continue to pose threats to human health
and put a financial burden on the healthcare system. The overuse of antibiotics has contributed to
mutations leading to the emergence of methicillin-resistant Staphylococcus aureus, and there is a
critical need for the discovery and development of new antibiotics to evade drug resistant bacteria.
Medicinal plants have shown promise as sources of new small molecule therapeutics with potential
uses against pathogenic infections. The Principal Rhode Island Secondary Metabolite (PRISM)
library is a botanical extract library generated from specimens in the URI Heber W. Youngken Jr.
Medicinal Garden by upper-division undergraduate students. PRISM extracts were screened for
activity against strains of methicillin-susceptible S. aureus (MSSA). An extract generated from the
tulip tree (Liriodendron tulipifera) demonstrated growth inhibition against MSSA, and a bioassayguided approach identified a sesquiterpene lactone, laurenobiolide, as the active constituent.
Intriguingly, its isomers tulipinolide and epi-tulipinolide lacked potent activity against MSSA.
Laurenobiolide also proved to be more potent against MSSA than the structurally similar
sesquiterpene lactones costunolide and dehydrocostus lactone. Laurenobiolide was most abundant
in the twig bark of the tulip tree, supporting the twig bark’s historical and cultural usage in
poultices and teas.

INTRODUCTION
Infections caused by pathogenic bacteria claim millions of lives yearly and accrue
billions of dollars in healthcare costs.1 The discovery and implementation of antibiotics to
combat pathogens have saved millions of lives worldwide since the discovery of penicillin by Sir
Alexander Fleming in 1928.2,3 Apart from inhibitors of cell wall biosynthesis like the β-lactam
antibiotics, other classes of antibiotic molecules with distinct mechanisms of action such as the
inhibition of protein biosynthesis, the inhibition of DNA synthesis, or the inhibition of folic acid
metabolism are now routinely utilized in the clinic.4 The pharmacophores for the majority of
these drugs were initially identified from natural products, primarily from microbial sources.5
However, the emergence and spread of antibiotic drug resistance among bacterial pathogens now
represent an existential threat to our healthcare systems.6
Staphylococcus aureus causes severe health and economic problems associated with
morbidity, mortality, and extended hospital stays due to invasive infections.7 While methicillinresistant S. aureus (MRSA) is of major concern in hospital settings, methicillin-susceptible S.
aureus (MSSA) can be the primary cause of invasive S. aureus infections in the hospital.8
Examining an infant cohort with invasive S. aureus infections from 1997-2012 showed that
infant mortality after infection was similar for MRSA and MSSA, and MSSA actually caused
more infant infections and more deaths than MRSA.9 Methicillin-susceptible Staphylococcus
aureus (MSSA) can infect multiple human organs, including the skin which is the most
prevalent. Untreated MSSA can lead to invasive infections in the bloodstream that lead to life
threatening conditions such as sepsis.10
Plant metabolites offer promise in providing new molecular scaffolds to use as antibiotics
either in isolation or in combination with currently used treatments to increase efficacy.11,12 The

same specialized metabolites that a plant may use to combat microbes in the environment can
potentially be harnessed to combat human pathogens. The tulip tree (Liriodendron tulipifera) has
been of interest to medicinal chemists for its purported biological properties and cultural and
historical use. Liriodendron tulipifera is a large flowering deciduous tree endemic across the
eastern United States. Indigenous Americans valued the tulip tree for its timber. Medicinally it
was utilized as a tonic, antipyretic, and anti-malarial agent.13-15 During the Civil War, Samuel
Preston Moore, Surgeon General of the Confederacy, responded to the blockade of medicines by
the Union Army by building new field hospitals and commissioning a study of medicinal plants
of the Southeast to treat soldiers. Francis Porcher led the search for alternative plant medicines,
conducting a deep study of the Southeast principally based on the cultural legacy of Cherokee
healers. He ultimately compiled a book containing plant remedies native to the Southern States
to help soldiers deal with injuries.16 One of the plants he highlighted was the tulip tree which was
used for rheumatism, gout, laxative, headache, malaria and other purposes.16-18 The described
bioactivities were later validated by discovery of anti-plasmodial aporphine alkaloids and
sesquiterpene lactones from the tree.19 While antibacterial activity has been demonstrated
historically from plant preparations and recently from extracts,15 no studies have yet identified
the antibacterial constituents of the tulip tree.
The Heber W. Youngken Jr. Medicinal Garden at the University of Rhode Island is a
botanical collection of nearly 300 medicinal plant species. In 2019, we developed an extract
library of aqueous and organic extracts of the aerial and root portions of specimens found in the
garden.20 This resource, the Principal Rhode Island Secondary Metabolite (PRISM) library, was
screened for antibiotic activity against MSSA. The library had 110 extracts from 26 plants at the
time this work was carried out.

Herein, we identified the organic (methanol) extract of the tulip tree leaves
(Liriodendron tulipera) as having growth inhibitory properties against S. aureus DMS 1104, an
MSSA strain. Using bioassay-guided isolation, the bioactive constituent was identified as the
sesquiterpene lactone laurenobiolide. We further investigated the relative abundance of this
compound in various parts of the tulip tree demonstrating that the compound was present in
higher concentrations in the twig bark when compared to other plant parts. Additionally, we
examined other Magnoliaceae specimens to determine if they produced laurenobiolide and other
related sesquiterpene lactones. Finally, we evaluated a panel of structurally similar sesquiterpene
lactones (Figure 1) for their ability to inhibit MSSA.

Figure 1. The primary active compound against MSSA was determined to be the sesquiterpene lactone laurenobiolide
in this study. Other sesquiterpene lactones identified from Liriodendron tulipifera and magnolias were tulipinolide,
epi-tulipinolide, costunolide, and dehydrocostus lactone.

RESULTS AND DISCUSSION

Screening the PRISM library for anti-MSSA activity revealed five active extracts from
the 110 tested. These were the methanol extracts of Amorpha fruticosa flowers and leaves, a
combined leaf and flower methanol extract from Isatis tinctora, a methanol extract from the
aerial parts of a Datura sp., and a methanol extract derived from L. tulipifera leaves that
provided reproducible activity against methicillin-susceptible S. aureus (Figure S1). This L.
tulipifera extract was subsequently prioritized for further study due to its documented historical
uses as an antimicrobial treatment. High performance liquid chromatography (HPLC) (Figure
S2) was used to visualize the complex metabolite profile leading to our strategy for bioassayguided fractionation. The tulip tree extract was first fractionated on a C18 column using a
stepwise gradient of CH3OH in H2O. Five fractions were generated, and the most robust activity
against MSSA was observed from constituents that eluted with 60% and 80% CH3OH (Figure
S3). A more polar fraction also initially displayed antibacterial activity, but upon retesting
individually isolated components, it seemed to be an additive effect of multiple compounds
rather than a single potent entity responsible for the activity. Upon visual analysis of the HPLC
chromatograms for each fraction, the most active fractions contained two large peaks that eluted
at 30 minutes from the column (Figure S3). We speculated that a compound in one of these
peaks could be responsible for the observed activity.
The two prominent peaks were isolated using semi-preparative HPLC and the latter
eluting peak exhibited the largest zone of inhibition in the MSSA assay (Figure S4A). The peak
purity was checked using a phenyl-hexyl column paired with HPLC-DAD analysis. We
determined that the earlier eluting peak (peak 1) was a single pure compound while the later
eluting peak was two separate analytes (Figure S4B). Upon repurification and retesting of the
three compounds, it was determined that only peak 2.1 had antimicrobial activity, while peaks 1

and 2.2 did not show any observable activity in the disk diffusion assay (Figure S4C). Analysis
and dereplication via 1D and 2D NMR (Figure S5 – S9 and S11) and HRESIMS (Figure S10)
revealed that these three metabolites were isomers and the active peak 2.1 was determined to be
laurenobiolide. HRESIMS of 2.1 gave an m/z of 313.1418 ([M+Na]+, calcd: 313.1416 for
C17H22O4Na). The specific rotation measured for peak 2.1: [α]23D 16.8 (c 1.0, EtOH) closely
matched the literature value of [α]25D 17.1 (EtOH) for laurenobiolide.21 Additionally,
examination of the 1H NMR spectra of peak 2.1 showed an envelope of olefinic protons from δ
4.70 to 5.50 consistent with the original characterization of this metabolite by Tada and Takeda
in 1971,22 and the 1H NMR spectrum clearly showed the presence of conformational isomers, a
phenomenon previously described for laurenobiolide during NMR analysis (Figure S6).23,24
Examination of correlations from COSY, HSQC, and HMBC NMR data confirmed the
identification (Figures S7-S9). Examination of 1H NMR spectra identified peak 1 as epitulipinolide (Figure S5), and peak 2.2 as tulipinolide (Figure S11). Evidence included a multiplet
resonance at δ 5.72 in peak 1 corresponding to H-8, which was in a cluster of resonances
between δ 4.76 and 5.03 in peak 2.2. Furthermore, the acetyl methyl groups at δ 2.09 and 2.06
were consistent with those of tulipinolide and epi-tulipinolide, respectively, as detailed in the
original isolation and elucidation work, as were the olefinic methyl resonances.25 Interestingly,
among these three sesquiterpene lactones that are extremely similar in structure (Figure 1), only
laurenobiolide displayed antibiotic activity towards S. aureus DMS 1104. The minimum
inhibitory concentration (MIC) for laurenobiolide and a panel of sesquiterpene lactones was
determined via broth dilution assay (Table 1). Laurenobiolide showed the strongest potency with
an MIC of 7.8 µg/mL. Costunolide, one of the terpenoids devoid of an acetyl group, had an MIC

value of 31 µg/mL. Epi-tulipinolide, tulipinolide and dehydrocostus lactone had MIC values of
62 µg/mL, 250 µg/mL, and 62 µg/mL, respectively.
Table 1. MIC values for sesquiterpene lactones tested
against S. aureus DSM 1104
Compound
MIC (µg/mL)
Laurenobiolide
Epi-tulipinolide
Tulipinolide
Costunolide
Dehydrocostus lactone
Honokiol
Gentamicin sulfate (positive control)

7.8
62
250
31
62
7.8
6.3

Laurenobiolide was evaluated for its cytotoxic effects to HaCaT cells, a commonly studied
human keratinocyte cell line. The compound demonstrated cytotoxic effects at 2.9 µg/mL showing
13% cell viability as compared to vehicle control (Figure S12). Epi-tulipinolide and tulipinolide
showed less cytotoxic activity against the HaCaT cells at 29 µg/mL with cell viability of 66% and
84%, respectively (Figure S12). Doses at 0.29 µg/mL and lower did not show cytotoxicity. These
observations are consistent with those of Dettweiler and coworkers, who showed that branch bark
extracts of L. tulipifera possessed some mammalian toxicity when tested against cells.15
Next, we investigated which parts of the tulip tree contained the highest concentrations of
laurenobiolide. HPLC-DAD and LC-MS/MS analysis were performed to evaluate the presence
of this constituent in the trunk bark, leaves, and twigs of the tulip tree. Laurenobiolide was most
abundant in the twigs, and low amounts were detected in the leaves, but no laurenobiolide was
detected in the trunk bark (Figure S13). These findings could be an artifact of the sampling
approach where outer bark pieces were removed non-invasively so as to not damage the tree.
Further analysis showed the presence of laurenobiolide in the twig bark, but not the inner twig
tissue (Figure S14). These observations are consistent withs some of the documented traditional

Cherokee uses of the twig bark for medicine,26 and these data will now inform future
investigations of plant parts while provoking intriguing questions about the ecological role of
laurenobiolide. Additionally, the twig itself showed zones of inhibition when tested against
MSSA, while other plant parts tested did not show activity (Figure 2). A poultice-like
preparation made with twigs and jojoba oil showed a zone of inhibition, while a portion of
‘stripped twig’ with the outer covering removed did not (Figure S15). This helps connect the
historic use of the twig bark poultices with the data on laurenobiolide discovered in this report.

Figure 2. MSSA inhibition assay with L. tulipifera plant parts. Twig, trunk bark, flower, and leaf were directly
placed onto MSSA plates. Plant parts were surface sterilized with methanol and dried prior to evaluation. The zone
of inhibition can be seen for the twig specimen. Gentamicin sulfate was used as the positive control.

We also examined several magnolia species for the presence of laurenobiolide and other
sesquiterpene lactones. Laurenobiolide, epi-tulipinolide, and tulipinolide were only detected in L.
tulipifera (Figure 3A and 3B). However, costunolide was detected in L. tulipifera, Magnolia
virginiana, and Magnolia acuminata (Figure 3C and Figure S16), and dehydrocostus lactone was
detected in M. macrophylla and M. virginiana (Figure S17). This was confirmed by comparison
of the extracts to authentic standards of dehydrocostus lactone and costunolide. Additionally,

costunolide and dehydrocostus lactone were identified as library hits on the GNPS Social
Molecular Networking website following library analysis (Figures S16 and S17).

Figure 3. Sesquiterpene lactones in Liriodendron tulipifera and three other Magnolia spp. A) Epi-tulipinolide (E),
laurenobiolide (L) and tulipinolide (T) were only detected in L. tulipifera extracts. B) An extracted ion chromatogram
(m/z 231) shows the base peak of the three acetylated sesquiterpene lactones in L. tulipifera, and an unidentified
metabolite in M. virginiana and M. acuminata. C) An extracted ion chromatogram (m/z 233) shows the presence of
costunolide in L. tulipifera, M. virginiana and M. acuminata. D) Amongst the magnolias tested, only the M.
macrophylla extract showed anti-MSSA activity. Gentamicin sulfate, an aminoglycoside antibiotic, was used as the
positive control (20 µg/disk; upper left quadrant on each plate). The test concentration of the extracts was 200 µg/disk,
and each extract was tested in duplicate. Negative controls are in the bottom left quadrant of each plate.

Interestingly, other than L. tulipifera, only the M. macrophylla extract showed inhibition
of MSSA amongst the magnolia extracts tested (Figure 3D). To determine the active components
in the M. macrophylla extract, we conducted bioassay-guided isolation. Following additional
inhibition tests, we characterized honokiol as the major antibacterial component in the M.

macrophylla extract (MIC = 7.8 µg/mL against MSSA). Honokiol has reported potent antiMSSA activity with MIC values as low as 2.5 µg/mL.27 The M. denudata extract did not show
the presence of any of the known sesquiterpene lactones on which we focused (Figure S18) and
its extract was inactive against MSSA (Figure 2D). Even though M. virginiana and M.
acuminata extracts contained costunolide, which showed modest inhibitory activity against
MSSA, the concentration was likely too low to show antibacterial activity.
While Magnolia and Liriodendron are both genera in the magnolia family, Liriodendron
is the only genus in the Liriodendroidae subfamily, which consists of two species: L. tulipifera
and L. chinense.28 Single nucleotide polymorphism analysis from DNA sequencing results of the
specimen used in the current report clearly showed that the specimen was a Liriodendron and
specifically L. tulipifera (Figure S19). It will be intriguing to examine authentic specimens of L.
chinense to compare the metabolite profile and sesquiterpene lactone composition between the
two Liriodendron species.
We searched for biosynthetic genes that could putatively generate sesquiterpene lactones
such as laurenobiolide in publicly available L. tulipifera RNAseq data. The search was based on
the pathway identified in Helianthus annuus.29 This pathway synthesizes a sesquiterpene lactone
from inunolide or eupatolide using germacrene-A synthase/hydroxylase, and a cytochrome P450
enzyme. This pathway is predicted to occur widely in Viridiplantae,30 and germacrene-A has
been identified in the closely related genus Magnolia.31 We recovered L. tulipifera transcripts for
farnesyl pyrophosphate synthase, cytochrome P450 (E-class, group IV), acetyl-CoA
acetyltransferase (cytosolic), and multiple terpene cyclases including germacrene D synthase
(Table S1). Although we found seven distinct terpene cyclases, we did not find a transcript with
sufficient homology to indicate the presence of germacrene A synthase or germacrene-A

hydroxylase in the L. tulipifera transcriptome. We would predict that laurenobiolide would
derive from germacrene A acid. Terpene cyclases can have wide substrate affinity,32 and it is
possible that laurenobiolide is being synthesized via a novel biosynthetic pathway. However, due
to the lack of a reference genome (this analysis utilized RNAseq data) it is also possible these
germacrene A genes were simply not expressed in the tissue at the time of collection. Further
genomic and transcriptomic investigations are needed to discern whether this compound is being
synthesized via an undescribed biosynthetic pathway, or with germacrene-A, as in Helianthus
annuus.
There has been a consistent effort to develop drugs with unique chemical scaffolds and
new mechanisms of action to combat pathogen resistance.33 While relatively few antibacterial
compounds have been identified in the terpene class, terpenes and terpenoids are an incredibly
diverse group of phytochemicals that possess potential as potent antimicrobials.34 The exact
mechanism of action of many terpene antibiotics is unknown, but Griffin and coworkers
identified that certain terpene metabolites inhibit two essential processes, which include oxygen
uptake and oxidative phosphorylation.35
CONCLUSION
The tulip tree extract has documented antimicrobial activity,15 yet the constituents
responsible for the activity had not been identified until now. In this report, we have determined
for the first time that the metabolite laurenobiolide isolated from Liriodendron tulipifera
possesses potent anti-MSSA activity and is the likely component responsible for the antiseptic
activity ascribed to the tulip tree. This work sheds light on the intriguing story of the cultural and
historical use of tulip tree preparations. The structural features that allow laurenobiolide to
inhibit MSSA growth, while very closely related structures do not inhibit growth, remains an

intriguing observation that we plan to explore in future studies. The most likely anti-MSSA
structural features would appear to be the position of double bonds and/or the absolute
configuration about the ring juncture. Furthermore, we have demonstrated the utility of the
PRISM library as a source of molecular potential in therapeutic areas, encouraging its future
expansion and use in screening efforts. Future research will focus on the mechanism of action of
laurenobiolide and its ecological role for the tree. Additionally, we will continue to search for
antibacterial components from magnolias and other botanical specimens.
MATERIALS AND METHODS
General Experimental Procedures. Optical rotations were measured using a Jasco P-2000
polarimeter. NMR spectra were recorded using an Agilent NMR 500 MHz spectrometer with
(CD3)2SO (referenced to residual DMSO at δH 2.50 and δC 39.5) or CDCl3 (referenced to residual
CHCl3 at δH 7.26 and δC 77.2) at 25 °C. HRESIMS analysis was performed using an AB SCIEX
TripleTOF 4600 mass spectrometer with Analyst software. MS/MS data were recorded on this
same instrument using the product ion function. LC-MS/MS was performed using a
ThermoFisher LTQ XL mass spectrometer with an electrospray ionization (ESI) source, and
certain mass spectrometry experiments (standard analysis) were completed using a ThermoFisher
ISQ mass spectrometer. Both the LTQ and ISQ were coupled to Dionex Ultimate 3000 HPLC
systems equipped with a micro vacuum degasser, an autosampler, and diode-array detector
(DAD). Semi-preparative and analytical HPLC was carried out using a Dionex UltiMate 3000
HPLC system equipped with a micro vacuum degasser, an autosampler, and a DAD. Standard
compounds, costunolide and dehydrocostus lactone, were purchased from Sigma-Aldrich.
Plant Harvesting and Preparation of Plant Extracts. Specimens of the tulip tree
(Liriodendron tulipifera L., Magnoliaceae), the yulan magnolia (Magnolia denudata Desr.,

Magnoliaceae, Kiri-01292), the sweetbay magnolia (Magnolia virginiana L., Magnoliaceae,
Kiri-01276), the cucumber tree (Magnolia acuminata L., Magnoliaceae, Kiri-01293), and the
bigleaf magnolia (Magnolia macrophylla Michx., Magnoliaceae, Kiri-01288) were harvested
from the University of Rhode Island campus, and voucher specimens of the magnolias can be
found in the KIRI herbarium. Biological material from the L. tulipifera specimen is held in the
lab of the corresponding author (voucher 8038051126). Plant extracts in the PRISM library were
prepared as previously described from specimens in the Heber W. Youngken Jr. Medicinal
Garden.20 Briefly, plants were separated into aerial and underground portions, then further
divided (twigs, leaves, etc.) for extraction in both aqueous and organic (methanol) solvents. Each
solvent was vacuum filtered to remove particulates, then either freeze-dried or evaporated under
reduced pressure to remove remaining solvent. Dried product was reconstituted at 10 mg/mL in
DMSO or CH3OH depending on solubility.
Methicillin-Susceptible Staphylococcus aureus Inhibition Assays. S. aureus strain DSM 1104
was cryopreserved and stored at -80 °C. The strain was grown in Luria Bertani (LB) broth
(Difco, Fisher scientific, Waltham, MA) at 37 °C, 150 rpm for 20 h. Plant extracts were prepared
as described above and 20 μL were loaded onto sterile antimicrobial susceptibility test disks
(Oxoid, Thermo Fisher, Franklin, MA). The disks were air dried for 30 min. Control disks were
prepared with 20 µL MeOH and similarly dried. The disks were then added to Petri dishes (100
× 15 mm) containing 15 mL of LB agar (Alpha biosciences, Baltimore, MD) inoculated with
DSM 1104. Plant parts that were directly tested against DSM 1104 were first sterilized by
wiping with CH3OH and then dried before testing. Gentamicin sulfate (20 µg/disk) was the
positive control for MSSA. Negative vehicle controls were DMSO or CH3OH (20 μL). Plates

were incubated at 37 °C for 18 h after which the diameters of the zones of growth inhibition were
measured to the nearest mm.
Minimum Inhibitory Concentration (MIC) of Sesquiterpene Lactones. Minimum inhibitory
concentrations (MICs) were determined in duplicate by broth microdilution in LB medium as
previously described,36 and in accordance with Clinical Laboratory Standards Institute (CLSI)
standards.37,38 Staphylococcus aureus DSM 1104 was obtained from the American Type Culture
Collection (ATCC 25923™). Test samples were prepared at 10 mg/mL in DMSO. Gentamicin
sulfate (2 mg/mL) in H2O was the positive control and DMSO was the negative control.
Bioassay Guided Fractionation of Crude Plant Extracts. We used 6.97 g of dried leaves for
initial extraction in CH3OH, which resulted in 140.5 mg of extract. The tulip tree leaf organic
extract was further fractionated using a C18 SPE cartridge to purify samples before additional
testing. Five fractions were produced from the extract, beginning with the most polar (80% H2O:
20% CH3OH) and ending with the least polar (100% CH3OH). Following solvent removal, the
chromatography fractions were reconstituted at 10 mg/mL in mobile phase followed by HPLCDAD analysis using a Thermo Scientific Acclaim™ 3 µm C18 column (150 × 3 mm). A 70 min
gradient method was utilized beginning with 15% acetonitrile (CH3CN) for 10 min, then
increasing the concentration of CH3CN until 45 min, with a 20 min hold at 100% CH3CN,
followed by a return to starting conditions for 5 min. Chromatograms were visually evaluated in
parallel with repeated antimicrobial assays to identify potentially active compounds.
Isolation of Sesquiterpene Lactones and Honokiol from Liriodendron tulipifera and
Magnolia macrophylla. Having identified the potential active components in the tulip tree
chromatography fractions following initial chromatogram analysis, fractions 3 (60% H2O/40%
CH3OH) and 4 (80% H2O/20% CH3OH) were combined and subjected to reversed-phase semi-

preparative HPLC using a Kinetex 5 μm C18 column (250 × 10 mm) and a gradient method. The
mobile phase was 60% CH3CN/40% H2O with 0.05% formic acid (FA) added to each solvent
with a flow rate of 3.0 mL/min. Initial conditions were held for 10.5 min followed by a linear
gradient to 12.0 min reaching 100% CH3CN and holding at this concentration for 4.0 min,
ultimately returning to initial conditions from min 17-20. Two chromatographic peaks were
collected at tR 9.5 (peak 1, epi-tulipinolide, 3.3 mg) and 10.0 min (peak 2), respectively. Peak 2
was further purified using a Luna® phenyl-hexyl 5 μm column (250 × 10 mm) and an isocratic
method. The mobile phase was 55% CH3CN/45% H2O with 0.05% FA added to each solvent and
a flow rate of 3 mL/min. Peaks 2.1 (laurenobiolide, 1.7 mg; tR 13.5 min) and 2.2 (tulipinolide,
1.5 mg; tR 14.25 min) were isolated. The CH3OH branch extract of M. macrophylla was
subjected to RP-HPLC using the same isocratic method as described above. The mobile phase
was 55% CH3CN/45% H2O with 0.05% FA added to each solvent and a flow rate of 3 mL/min.
A single peak eluting at 18.25 min was collected and identified as honokiol (4 mg).
Laurenobiolide (major conformer): colorless oil; [α]23D +16.8 (c 1.0, EtOH) 1H NMR (DMSOd6, 500 MHz) δ 6.14 (1H, br s, H-13a), 5.86 (1H, br s, H-13b), 5.45 (1H, t, J = 9.9 Hz, H-6), 5.15
(1H, m, H-1), 4.72 (1H, t, J = 10.8 Hz, H-5), 4.24 (1H, dd, J = 9.5, 6.5 Hz, H-8), 3.27 (1H, m, H7), 2.32 (1H, m, H-2a), 2.14 (1H, m, H-3a), 2.11 (2H, m, H-9), 2.10 (1H, m, H-2b), 1.98 (1H, m,
H-3b), 2.03 (3H, s, H-17), 1.59 (3H, s, H-15), 1.58 (3H, s, H-14); 13C NMR (DMSO-d6, 125
MHz) δ 169.7 (C, C-12), 169.6 (C, C-16), 139.3 (C, C-4), 138.1 (C, C-10), 130.3 (C, C-11),
128.9 (CH2, C-13), 126.4 (CH, C-5), 125.4 (CH, C-1), 79.8 (CH, C-8), 71.8 (CH, C-6), 50.2
(CH, C-7). 38.4 (CH2, C-3), 35.9 (CH2, C-9), 24.7 (CH2, C-2), 23.1 (CH3, C-17), 21.3 (CH3, C15), 21.2 (CH3, C-14); HRESIMS m/z 313.1418 ([M+Na]+ (calcd for C17H22O4Na, 313.1416).

The laurenobiolide 1H NMR data have been deposited at NP-MRD (npmrd.org/natural_products) (NP0048592).
LC-MS/MS Analysis of L. tulipifera Plant Parts and Magnolia Specimens and Database
Searching. Samples of tulip tree trunk, twig, and leaf were taken from the L. tulipifera specimen
on the URI campus and methanol extracts were made using 1.0 g portions of each L. tulipifera
plant part. Additionally, twig extracts were generated from 1 g portions of M. denudata, M.
virginiana, M. acuminata, and M. macrophylla. Each extract was subjected separately to HPLCDAD and LC-MS/MS analysis with a specific scan event recording MS/MS spectra in datadependent acquisition mode. A Kinetex 5 μm C18 column (150 × 4.6 mm) was used for
separation of analytes in the extracts. The LC method consisted of a linear gradient from 15% to
100% CH3CN in H2O + 0.1% FA over 20 min, followed by an isocratic period at 100% CH3CN
of 5 min. The flow rate was held constant at 0.4 mL/min. The MS spray voltage was 3.5 kV with
a capillary temperature of 325 °C. For the MS/MS component, the CID isolation width was 1.0
and the collision energy was 35.0 eV. Following acquisition, the raw data files were converted to
.mgf format using MSConvert from the ProteoWizard suite
(http://proteowizard.sourceforge.net/tools.shtml). Library searching was performed using the
online platform at Global Natural Products Social Molecular Networking website
(gnps.ucsd.edu).39 Both raw LC-MS/MS files and converted .mzXML files are available in a
MassIVE dataset - accession MSV000089948.
Detection of Sesquiterpene Lactones in L. tulipifera Plant Parts and Magnolias. L. tulipifera
twig, leaf, and trunk bark CH3OH extracts (10 mg/mL) were subjected to HPLC-DAD analysis
to evaluate the presence of laurenobiolide. Branch CH3OH extracts from L. tulipifera, M.
denudata, M. virginiana, M. acuminata, and M. macrophylla were subjected to HPLC-DAD and

LC-MS/MS analysis to specifically investigate the presence of the sesquiterpene lactones epitulipinolide, laurenobiolide, and tulipinolide. The chromatography parameters for HPLC-DAD
and LC-MS/MS were identical. The Luna® phenyl-hexyl 5 μm column (250 × 4.6 mm) was used
for separation of analytes. The mobile phase was 55% CH3CN/45% H2O with 0.05% formic acid
added to each solvent and flow rate of 0.6 mL/min. Following the HPLC-DAD and LC-MS/MS
analysis, the presence of costunolide and dehydrocostus lactone was confirmed by
chromatographic comparison to authentic standards using the method described above. These
raw LC-MS/MS files and converted .mzXML files are also available in the same MassIVE
dataset - accession MSV000089948.
Culturing Human Keratinocytes (HaCaT). Human keratinocytes (HaCaT) were a kind gift
from the laboratory of Dr. Navindra Seeram at URI, and originally purchased from American
Type Cell Culture Collection. The culture was maintained in Dulbecco’s modified Eagle’s
medium (DMEM) and the DMEM was supplemented with 10% fetal bovine serum. The
incubator was kept at 37 °C with 5% CO2 at constant humidity. All test samples were dissolved
in sterile DMSO for viability assessments.
Cytotoxic Evaluation of Keratinocytes (HaCaT) in the Presence of L. tulipera Compounds.
The viability of HaCaT cells in the presence of laurenobiolide, tulipinolide, and epi-tulipinolide
was evaluated using cell titer glo (CTG 2.0). HaCaT cells were seeded in a sterile 96-well plate
at 5×103 cells per well and incubated for 12 h. Post incubation, the media was removed, and
compounds were added along with new media, followed by a 24 h incubation. The CTG 2.0
reagent was added to each well and shaken at 200 rpm for 2 min using an orbital shaker. The
plate was allowed to equilibrate at room temperature for 10 min, and then the luminescence was
recorded using a Spectramax M2 plate reader. Viability was determined by comparing

luminescence values of treated wells to those of the vehicle control (DMSO) (n = 4 per
treatment). Cannabidiol (31 µg/mL) was used as a positive control.40
Identifying Putatively Useful Nuclear Markers from Whole-Genome Sequence (WGS)
Data. We used the SISRS bioinformatics package41 to develop nuclear genetic markers for the
(1) delineation of Liriodendron spp. from other Magnoliaceae and (2) to delineate L. chinese and
L. tulipifera. WGS data for six L. tulipifera, six L. chinese, and 83 specimens of Magnolia spp.
were downloaded from the NCBI SRA database (https://www.ncbi.nlm.nih.gov/sra). All read
data were trimmed using the bbmap suite (https://sourceforge.net/projects/bbmap/) using a
sliding-window with a Q10 cutoff and removing reads with a final average quality less than Q15
and/or length less than 50 bp. To enrich each dataset for nuclear data, we then used bbmap to
remove any reads that mapped against a pooled set of 253 chloroplast assemblies and 5
mitochondrial assemblies downloaded from NCBI. Based on a nuclear genome size estimate for
the group of 2.5 Gb, we subset reads from each species such that the final combined read depth
was ~25 Gb (10X coverage), with reads sampled evenly across the 69 species and specimens
therein. These subset reads were then pooled and used as input for a genome assembly using Ray
with default parameters,42 with the resulting assembly representing loci that are conserved
enough among species to be assembled and compared easily among taxa.
Identifying Fixed Sites for Use in Species and Genus Delineation Assays. To identify
genomic sites that would be useful for species delineation between Liriodendron species, we
mapped the trimmed reads from all twelve Liriodendron specimen against the SISRS composite
genome using bbmap and identified all sites that were (1) fixed and identical within species for
all six L. tulipifera or L. chinese specimens and (2) variable between species. A total of 164,710
species-specific SNPs were identified.

To identify SNPs that can delineate Liriodendron from Magnolia, we first identified all
sites in the composite genome that were fixed and identical among all twelve Liriodendron
specimens. Next, after setting aside eight Magnolia specimens for downstream testing, we
removed any sites where those fixed Liriodendron alleles were found in any of the remaining 73
Magnolia samples. Magnolia samples had variable read coverage, and not finding a
Liriodendron specific allele could be due to either (1) the allele not being present or (2) the allele
not being sampled. To make a more conservate estimate of robust genus-specific SNPs, we only
considered SNPs where there was read coverage in at least half (n=38) of the Magnolia
specimens. A total of 630,741 Liriodendron-specific SNPs were identified.
Testing Genus- and Species-Specific Genetic Markers. To assess the ability of the genetic
SNP markers to identify samples to the genus and species level, we mapped read data from eight
Magnolia specimens, two L. tulipifera samples, and one L. chinese sample against the SISRS
composite genome. Alleles at sites identified above were queried for all samples, and the
proportion of sites matching either (1) the Liriodendron genus-specific allele or (2) the L.
tulipifera or L. chinese specific allele was tabulated.
For genus-level screening, individual samples had coverage for 83,908 – 594,416 genus
SNPs per specimen. The three Liriodendron samples had the matching Liriodendron allele at
99.2% - 99.9% of surveyed sites, while no more than 0.44% of sites had the corresponding allele
across the eight Magnolia samples. For species-level screening, the three Liriodendron samples
had coverage for 22,094 – 152,985 sites per specimen. The L. chinese-specific allele was
detected at over 99% of sites in the L. chinese sample, while fewer than 2% of sites contained the
allele in either L. tulipifera sample. In parallel, 97.5% - 99.4% of sites in the two L. tulipifera

samples had the L. tulipifera-specific allele, while it was found in only 0.21% of sites for the L.
chinese sample.
Evaluation of Potential Biosynthetic Genes. Publicly available Liriodendron tulipifera
RNAseq data originally collected from apical shoots was retrieved from SRA (SRR16546781,
SRR16546782, SRR16546783, SRR16546784, SRR16546785, SRR16546803, SRR16546804),
trimmed with Trimmomatic (v0.39),43 and assembled using rnaSPAdes (v3.15.3).44 This resulted
in 332,056 transcripts, with an average length of 1,011 bp. Transdecoder
(https://github.com/TransDecoder/TransDecoder) was then run to predict reading frames of the
resulting transcripts, resulting in 189,683 predicted proteins. These proteins were annotated with
KEGG,45 Interpro,46 and a custom BLAST47 database comprised of biosynthetic genes that
produced sesquiterpenes such as costunolide in other plant species.
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